You are here

Press Releases

Texas communities facing a rural hospital closure should not solely concentrate on whether or not to close a hospital, but instead focus on the available health resources in the surrounding area. That’s one of the findings of a new report by the Texas A&M Rural and Community Health Institute (RCHI) that examined rural hospital closures and looks at new solutions for rural healthcare concerns. The Episcopal Health Foundation (EHF) sponsored the report. 

 eClinicalWorks®, a leader in healthcare IT solutions, announced today that its telehealth solution is now available on the company’s Health & Online Wellness (healow™) mobile app to provide patients with live video visits. This TeleVisits feature is integrated within the eClinicalWorks comprehensive electronic health records (EHR) offering and all information submitted or shared by patients using this solution can be imported into the EHR. This supports workflow, clinical research and improves patient satisfaction with access to care whenever and wherever it’s needed.

Surefire Medical, Inc., the developer of site-specific delivery devices for the Interventional Oncology market, announced today results from a retrospective analysis of 85 bridge-to-transplant liver cancer patients treated with transarterial chemoembolization (DEB-TACE) that shows therapy delivery with the Surefire Infusion System was associated with an 80 percent complete response in one treatment versus 52 percent with a standard endhole microcatheter. In addition, the analysis shows a statistically significant lower recurrence rate of liver cancer at one month of 13 percent using Surefire technology versus 52 percent recurrence with a standard microcatheter.

 Royal Philips (NYSE: PHG AEX: PHIA) today announced the relaunch of its innovative Pioneer Plus catheter, the first and only re-entry device with intravascular ultrasound (IVUS) capabilities and needle deployment designed to assist arterial vessel intervention. IVUS captures images of vessels in the peripheral vascular system from inside the artery, allowing physicians to identify a targeted area and place a catheter in a specific location and to help guide the treatment partially or fully blocked arteries.

SAN FRANCISCO--(BUSINESS WIRE)--Kenzen, an innovator of wearables for precision health, today announced it has raised $5 million from multiple investors to further development, support and market positioning of its ECHO Smart Patch wearable technology. Kenzen’s smart wearable patch continuously uses non-invasive sweat analysis to measure vital signs and motion sensors to predict and prevent avoidable injuries and illness.

LexisNexis® Risk Solutions and the American Medical Association (AMA) have launched the Verify Health Care Portal, the clinician attestation component of VerifyHCP, a robust solution for monitoring physician information that simplifies a successful data strategy for managing a health plan network.

Salus Telehealth, Inc., a market leader and trusted advisor within the telehealth industry, is partnering with Dreamcatcher Artist Management to provide touring recording artists, including rising country star Mo Pitney, with access to their personal physicians via Salus’ VideoMedicine platform while on the road.

ArisGlobal, a leading provider of integrated, cloud-based software solutions for life sciences announces LifeSphere Safety - Risk Management™, a multi-tenant, cloud-based solution that offers a comprehensive set of data analytics, workflow and reporting tools for end-to-end signal detection and risk management.

When a child falls ill, receiving the right emergency care at the right time is crucial for recovery. Unfortunately, specialized pediatric emergency rooms can be far away, further delaying diagnosis and treatment in a time of need. To ensure children receive the urgent care they need, regardless of location, Robert Wood Johnson University Hospital (RWJUH) now offers emergency pediatric telemedicine, connecting patients to physicians on its Somerset campus with pediatric emergency medicine at the Bristol-Myers Squibb Children’s Hospital (BMSCH) at RWJUH in New Brunswick through a secure, remote network.

The American Medical Association (AMA) and West Monroe Partners today announced that the AMA has received a 2017 Gold Trumpet Award in the category of Internal Communications-Employee.

In the ICD-9 era, there were universally accepted benchmarks to measure coding professionals’ productivity. Now, more than 18 months after the ICD-10 implementation date, the challenge is to do the same for the new coding system.

BioTelemetry, Inc. (NASDAQ:BEAT), the leading wireless medical technology company focused on the delivery of health information to improve quality of life and reduce cost of care, announced today that LifeWatch’s largest shareholders, including Himalaya TMT Fund, Aevis Victoria SA and Antoine Hubert, pledged support of the Company’s tender offer for all outstanding shares of LifeWatch AG (SIX:LIFE) and have agreed to tender their shares. 

MCHENRY, IL. May 30, 2017 – Medela Healthcare announces the launch of the new Invia® FitPad™ Negative Pressure Wound Therapy dressing portfolio, making NPWT easier for healthcare professionals and patients. “With the launch of this versatile portfolio of devices and dressings, Medela’s new NPWT portfolio supports easier patient transitions from hospital to home. Our NPWT solutions are designed for ease-of-use by clinicians and patients”, states Dan Hyun, Vice President Medela Healthcare US.

Orbita, Inc., a leading provider of voice-first software for connected home healthcare announced today a collaboration withERT to research innovative new approaches to data procurement and management for pharmaceutical and device customers seeking to streamline clinical trials. The collaboration combines the advanced capabilities of ERT’s EXPERT™ technology platform for clinical trial data collection, processing, and analysis with Orbita Voice™, a first-of-its-kind solution for creating conversational applications using intelligent voice agents such as Amazon Alexa and Google Assistant.

Researchers at Mayo Clinic have identified a possible cause for a rare infection in heart and lung transplant recipients: the donor. The way in which heart and lung transplant recipients acquired a specific species of bacteria, Mycoplasma hominis, had been previously undefined, and the bacterium was difficult to test. Originally, this bacterium was considered to reside exclusively in, and be a potential pathogen of, the area of the reproductive and urinary organs – the genitourinary tract.

Midmark Corporation, a leading medical solutions provider for ambulatory care, and Masimo (NASDAQ: MASI), a global leader in innovative noninvasive monitoring technologies, today announced a partnership focused on improving the accuracy and efficiency of vital signs acquisition in the clinical space. 

Spok, Inc., a wholly owned subsidiary of Spok Holdings, Inc. (NASDAQ: SPOK) and the global leader in healthcare communications, today announced that Mark A. Costanza has joined the company in a new role as its Senior Vice President of Professional Services. The addition of this role reflects Spok’s plans to broaden its portfolio of professional services and expand its enterprise delivery services.

The digital pathology industry just took another step forward, with the FDA clearance of a whole slide imaging (WSI) system (Philips IntelliSite™ Pathology Solution) for review of digital surgical pathology slides. Leica Biosystems congratulates both the FDA and the Digital Pathology Association (DPA) on this positive outcome from their ongoing collaboration.

Carestream will demonstrate its CARESTREAM OnSight 3D Extremity System (see video link) that uses cone beam CT (CBCT) technology to capture high-quality, low-dose 3D extremity exams at the American College of Sports Medicine (ACSM) annual meeting that begins May 30. This conference is one of the largest sports medicine and exercise science conferences in the world.

WALTHAM, MA, May 4, 2017 – A multi-center post-hoc analysis presented at the American Association of Clinical Endocrinologists (AACE) 26th Annual Scientific & Clinical Congress by Drs. Jagdeesh Ullal and Joseph Aloi demonstrates that Glytec’s eGlycemic Management System® (eGMS®) enables hospitals to achieve the basal bolus standard of care for subcutaneous insulin therapy with extraordinary efficiency and superior patient outcomes. The new research study, entitled ‘AUTO Study, AUtomatic Titration tO Target: Subcutaneous Basal Bolus Insulin Management Using eGMS in the Non-ICU Setting,’ observed a 19% reduction in average daily blood glucose between admission and discharge -- with 0.00% severe hypoglycemia <40 mg/dL -- while achieving the prescribed target blood glucose of 140-180 mg/dL at all mealtime and bedtime intervals.